136 related articles for article (PubMed ID: 10649827)
1. Increase of dialysate dopamine in the bed nucleus of stria terminalis by clozapine and related neuroleptics.
Carboni E; Rolando MT; Silvagni A; Di Chiara G
Neuropsychopharmacology; 2000 Feb; 22(2):140-7. PubMed ID: 10649827
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of dopamine release in the bed nucleus of stria terminalis. A trait of atypical antipsychotics?
Carboni E; Silvagni A; Rolando MT; Di Chiara G
Ann N Y Acad Sci; 1999 Jun; 877():707-10. PubMed ID: 10415689
[No Abstract] [Full Text] [Related]
3. BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex.
Volonté M; Monferini E; Cerutti M; Fodritto F; Borsini F
J Neurochem; 1997 Jul; 69(1):182-90. PubMed ID: 9202309
[TBL] [Abstract][Full Text] [Related]
4. Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.
Hertel P; Nomikos GG; Iurlo M; Svensson TH
Psychopharmacology (Berl); 1996 Mar; 124(1-2):74-86. PubMed ID: 8935802
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex.
Gessa GL; Devoto P; Diana M; Flore G; Melis M; Pistis M
Neuropsychopharmacology; 2000 Jun; 22(6):642-9. PubMed ID: 10788763
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs.
Carboni E; Silvagni A; Rolando MT; Di Chiara G
J Neurosci; 2000 Oct; 20(20):RC102. PubMed ID: 11027253
[TBL] [Abstract][Full Text] [Related]
7. Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex.
Nomikos GG; Iurlo M; Andersson JL; Kimura K; Svensson TH
Psychopharmacology (Berl); 1994 Jun; 115(1-2):147-56. PubMed ID: 7862887
[TBL] [Abstract][Full Text] [Related]
8. Effects of risperidone, clozapine and haloperidol on extracellular recordings of substantia nigra reticulata neurons of the rat brain.
Bruggeman R; Westerink BH; Timmerman W
Eur J Pharmacol; 1997 Apr; 324(1):49-56. PubMed ID: 9137912
[TBL] [Abstract][Full Text] [Related]
9. Atypical neuroleptic drugs downregulate dopamine sensitivity in rat cortical and striatal astrocytes.
Reuss B; Unsicker K
Mol Cell Neurosci; 2001 Aug; 18(2):197-209. PubMed ID: 11520180
[TBL] [Abstract][Full Text] [Related]
10. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
Hertel P; Nomikos GG; Svensson TH
Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809
[TBL] [Abstract][Full Text] [Related]
11. Risperidone dose-dependently increases extracellular concentrations of serotonin in the rat frontal cortex: role of alpha 2-adrenoceptor antagonism.
Hertel P; Nomikos GG; Schilström B; Arborelius L; Svensson TH
Neuropsychopharmacology; 1997 Jul; 17(1):44-55. PubMed ID: 9194049
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain.
Westerink BH; de Boer P; de Vries JB; Kruse CG; Long SK
Eur J Pharmacol; 1998 Nov; 361(1):27-33. PubMed ID: 9851538
[TBL] [Abstract][Full Text] [Related]
13. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
Li Z; Huang M; Prus AJ; Dai J; Meltzer HY
Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474
[TBL] [Abstract][Full Text] [Related]
14. Some, but not all, antipsychotic drugs potentiate a low level of prepulse inhibition shown by rats of the Wistar strain.
Depoortere R; Perrault G; Sanger DJ
Behav Pharmacol; 1997 Aug; 8(4):364-72. PubMed ID: 9832995
[TBL] [Abstract][Full Text] [Related]
15. Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat.
Shirazi-Southall S; Rodriguez DE; Nomikos GG
Neuropsychopharmacology; 2002 May; 26(5):583-94. PubMed ID: 11927183
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism.
Duncan GE; Miyamoto S; Leipzig JN; Lieberman JA
J Pharmacol Exp Ther; 2000 Apr; 293(1):8-14. PubMed ID: 10734147
[TBL] [Abstract][Full Text] [Related]
17. Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation.
Heidbreder CA; Foxton R; Cilia J; Hughes ZA; Shah AJ; Atkins A; Hunter AJ; Hagan JJ; Jones DN
Psychopharmacology (Berl); 2001 Jul; 156(2-3):338-51. PubMed ID: 11549234
[TBL] [Abstract][Full Text] [Related]
18. Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum.
Ichikawa J; Dai J; O'Laughlin IA; Fowler WL; Meltzer HY
Neuropsychopharmacology; 2002 Mar; 26(3):325-39. PubMed ID: 11850147
[TBL] [Abstract][Full Text] [Related]
19. The olfactory tubercle as a site of action of neuroleptics with an atypical profile in the paw test: effect of risperidone, prothipendyl, ORG 5222, sertindole and olanzapine.
Cools AR; Prinssen EP; Ellenbroek BA
Psychopharmacology (Berl); 1995 Jun; 119(4):428-39. PubMed ID: 7480523
[TBL] [Abstract][Full Text] [Related]
20. The discriminative stimulus properties of the atypical antipsychotic olanzapine in rats.
Porter JH; McCallum SE; Varvel SA; Vann RE
Psychopharmacology (Berl); 2000 Feb; 148(3):224-33. PubMed ID: 10755735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
